Discussing the Science of CBD - Part Two - PPN Episode 750 скачать в хорошем качестве

Discussing the Science of CBD - Part Two - PPN Episode 750

Part Two of the three part series on CBD Part Two with CV Sciences Stuart Tomc Vice Presdient of Human Nutrition talking with Dr. Hector L. Lopez Jr., MD, CSCS, FAAPMR. Here's part one:   / discussing-the-science-of-cbd   CV Science: pluscbdoil.com/ Contact CV Sciences: (800) 561-8711 [email protected] About CV Sciences MISSION At CV Sciences, our mission to improve well‐being underscores our values, operations, and products. OVERVIEW CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities. PHARMACEUTICALS CV Sciences’ Pharmaceutical Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for treatment of a range of medical conditions. CONSUMER PRODUCTS CV Sciences’ Consumer Products Division delivers botanical‐based cannabidiol products that enhance quality of life. Currently distributed nationally in health food stores, health care provider’s offices and online, each consumer products brand is backed by a formal safety review, growing body of case reports, and physician’s recommendations.